Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127578051 | 12757805 | 1 | I | 20160907 | 20160919 | 20160919 | EXP | US-TEVA-693508USA | TEVA | 40.00 | YR | M | Y | 0.00000 | 20160919 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127578051 | 12757805 | 1 | PS | OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML | OXALIPLATIN | 1 | Unknown | U | 22160 | ||||||||||
| 127578051 | 12757805 | 2 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | U | 71198 | ||||||||||
| 127578051 | 12757805 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 40333 | ||||||||||
| 127578051 | 12757805 | 4 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 78122 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127578051 | 12757805 | 1 | Pancreatic carcinoma |
| 127578051 | 12757805 | 2 | Pancreatic carcinoma |
| 127578051 | 12757805 | 3 | Pancreatic carcinoma |
| 127578051 | 12757805 | 4 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127578051 | 12757805 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127578051 | 12757805 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |